malondialdehyde has been researched along with yohimbine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SN; Kim, YC; Yoon, MY | 1 |
| Alp, HH; Borekci, B; Karaca, M; Kumtepe, Y; Salman, S; Suleyman, H | 1 |
| Akcay, F; Calik, M; Cetin, N; Gundogdu, C; Ingec, M; Isaoglu, U; Kurt, A; Polat, B; Suleyman, H; Yilmaz, M | 1 |
| Chen, JH; Jin, SY; Lei, DX; Song, XR; Yu, GF; Zhang, WH; Zhou, SL | 1 |
| Fu, G; Jiang, L; Li, L; Shen, J | 1 |
| Cui, E; Li, M; Sun, J; Yan, M; Zhang, H; Zhang, Y; Zhou, J; Zhu, X | 1 |
| Li, G; Liu, B; Wei, J; Zhou, J | 1 |
7 other study(ies) available for malondialdehyde and yohimbine
| Article | Year |
|---|---|
Potentiation of acetaminophen hepatotoxicity by acute physical exercise in rats.
Topics: Acetaminophen; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alanine Transaminase; Analgesics; Animals; Aspartate Aminotransferases; Dose-Response Relationship, Drug; Female; Glutathione; Lipid Peroxidation; Liver; Malondialdehyde; Physical Conditioning, Animal; Prazosin; Propranolol; Rats; Rats, Sprague-Dawley; Time Factors; Vitamin E; Yohimbine | 1997 |
Effect of acute and chronic administration of progesterone, estrogen, FSH and LH on oxidant and antioxidant parameters in rat gastric tissue.
Topics: Adrenergic alpha-Antagonists; Animals; Estrogens; Female; Follicle Stimulating Hormone; Gastric Mucosa; Glutathione; Hormone Antagonists; Luteinizing Hormone; Malondialdehyde; Mifepristone; Oxidative Stress; Peroxidase; Progesterone; Rats; Rats, Wistar; Stomach; Superoxide Dismutase; Yohimbine | 2009 |
An investigation about the inhibition of acute ischemia/reperfusion damage by dexmedetomidine in rat ovarian tissue.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Biomarkers; Dexmedetomidine; DNA Damage; Female; Glutathione; Guanine; Ischemia; Lipid Peroxidation; Malondialdehyde; Ovary; Protective Agents; Rats; Rats, Wistar; Reperfusion Injury; Yohimbine | 2013 |
Activation of α2 adrenoceptor attenuates lipopolysaccharide-induced hepatic injury.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Chemical and Drug Induced Liver Injury; Cytoprotection; Dexmedetomidine; Disease Models, Animal; Interleukin-1beta; Interleukin-6; Lactic Acid; Lipopolysaccharides; Liver; Male; Malondialdehyde; Oxidative Stress; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Sepsis; Superoxide Dismutase; Time Factors; Tumor Necrosis Factor-alpha; Yohimbine | 2015 |
[Effect of dexmedetomidine hydrochloride on H2O2-induced oxidative stress and inflammatory response in Kupffer cells].
Topics: Adrenergic alpha-2 Receptor Antagonists; Cell Survival; Cells, Cultured; Dexmedetomidine; Humans; Hydrogen Peroxide; Kupffer Cells; L-Lactate Dehydrogenase; Malondialdehyde; Oxidative Stress; Receptors, Adrenergic, alpha-2; Tumor Necrosis Factor-alpha; Yohimbine | 2016 |
Dexmedetomidine attenuates sevoflurane‑induced neurocognitive impairment through α2‑adrenoceptors.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Caspase 3; Cognitive Dysfunction; Dexmedetomidine; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Morris Water Maze Test; Random Allocation; Sevoflurane; Superoxide Dismutase; Treatment Outcome; Yohimbine | 2021 |
Dexmedetomidine Ameliorated Cognitive Dysfunction Induced by Intestinal Ischemia Reperfusion in Mice with Possible Relation to the Anti-inflammatory Effect Through the Locus Coeruleus Norepinephrine System.
Topics: Adrenergic Antagonists; Animals; Anti-Inflammatory Agents; Benzylamines; Cognitive Dysfunction; Dexmedetomidine; Eosine Yellowish-(YS); Hematoxylin; Ischemia; Locus Coeruleus; Malondialdehyde; Mice; Neuroprotective Agents; Neurotoxins; Norepinephrine; Reperfusion; Reperfusion Injury; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase; Yohimbine | 2022 |